DECR2, a 2,4‐dienoyl‐CoA reductase 2, was reportedly involved in cell proliferation in prostate cancer cell lines, since lentiviral vector‐mediated overexpression intensified cell growth [28]. This evidence concerns the gene DECR2 and prostate cancer.